Edition:
United Kingdom

VistaGen Therapeutics Inc (VTGN.OQ)

VTGN.OQ on NASDAQ Stock Exchange Capital Market

1.22USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$1.22
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
160,266
52-wk High
$3.91
52-wk Low
$0.69

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
-0.50

Analyst Recommendations and Revisions

No analyst recommendations and revisions data available.

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 2 0.00 0.00 0.00 --
Year Ending Mar-17 2 1.25 1.25 1.25 --
Earnings (per share)
Quarter Ending Mar-17 2 -0.50 -0.49 -0.52 --
Year Ending Mar-17 2 -1.76 -1.73 -1.79 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-17 0.00 0.00 0.00 0.00
Quarter Ending Mar-17 0.00 0.00 0.00 0.00
Quarter Ending Dec-16 0.00 1.25 1.25 0.00
Quarter Ending Sep-16 0.00 0.00 0.00 0.00
Quarter Ending Jun-16 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Jun-17 -0.47 -0.28 0.19 -39.78
Quarter Ending Mar-17 -0.50 -0.31 0.19 -38.61
Quarter Ending Dec-16 -0.37 -0.34 0.03 -8.11
Quarter Ending Sep-16 -0.38 -0.42 0.04 -10.53
Quarter Ending Jun-16 -0.56 -0.51 0.05 -8.93

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 0.00 -- -- -- --
Year Ending Mar-17 1.25 -- -- -- --
Earnings (per share)
Quarter Ending Mar-17 -0.50 -- -- -- --
Year Ending Mar-17 -1.76 -- -- -- --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-17 -- -- -- --
Year Ending Mar-17 -- -- -- --
Earnings
Quarter Ending Mar-17 -- -- -- --
Year Ending Mar-17 -- -- -- --